Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment

Clin Perinatol. 1995 Jun;22(2):457-79.

Abstract

This article presents a comprehensive review of the patent ductus arteriosus which so often affects the premature neonate. Included are a discussion of the unique anatomy and physiology of the ductus, a review of the mechanisms involved in normal closure, and factors leading to persistent patency. Various therapeutic options also are discussed, including some new and innovative approaches.

Publication types

  • Review

MeSH terms

  • Ductus Arteriosus / anatomy & histology
  • Ductus Arteriosus / drug effects
  • Ductus Arteriosus / physiology
  • Ductus Arteriosus, Patent / drug therapy*
  • Ductus Arteriosus, Patent / pathology
  • Ductus Arteriosus, Patent / physiopathology*
  • Female
  • Humans
  • Indomethacin / administration & dosage
  • Indomethacin / pharmacology
  • Indomethacin / therapeutic use*
  • Infant, Newborn
  • Infant, Premature*
  • Infant, Premature, Diseases / drug therapy*
  • Infant, Premature, Diseases / physiopathology*
  • Oxygen / blood
  • Pregnancy
  • Prostaglandins / physiology*

Substances

  • Prostaglandins
  • Oxygen
  • Indomethacin